ad image

Drug Discovery Platform

1 / 1
Gb Sciences, Inc.
Parkinson's Disease Research

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

Gb Sciences, Inc.

PR-M04-22-08Apr 12, 2022
Developing New Antibody Therapeutics for COVID-19 and Beyond
Antibody Therapeutics

Developing New Antibody Therapeutics for COVID-19 and Beyond

Ian Chan

Abpro

PAO-01-22-CL-01Mar 12, 2022
Uncovering New Drug Targets for Neurological Diseases
Neurodegenerative Diseases

Uncovering New Drug Targets for Neurological Diseases

Brad Margus

Cerevance

PAO-02-022-CL-10Mar 12, 2022
1 / 1